Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

BACKGROUND: Until 50% of patients with renal cancer or melanoma, develop brain metastases during the course of their disease. Stereotactic radiotherapy has become a standard of care for patients with a limited number of brain metastases. Given the radioresistant nature of melanoma and renal cancer,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: Lesueur, Paul, Lequesne, Justine, Barraux, Victor, Kao, William, Geffrelot, Julien, Grellard, Jean-Michel, Habrand, Jean-Louis, Emery, Evelyne, Marie, Brigitte, Thariat, Juliette, Stefan, Dinu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064124/
https://ncbi.nlm.nih.gov/pubmed/30055640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1083-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars